Literature DB >> 18528283

A comparative immunohistochemical analysis of small round cell tumors of childhood: utility of peripherin and alpha-internexin as markers for neuroblastomas.

Vickie Willoughby1, Anuj Sonawala, Ada Werlang-Perurena, Ludvik R Donner.   

Abstract

Immunohistochemical study of neuroblastomas, Ewing sarcomas, rhabdomyosarcomas, and Wilms tumors demonstrate specific expression of peripherin and alpha-internexin in 20/22 and 6/22 cases of neuroblastomas, respectively. Microtubule-associated protein 1B (MAP 1B) was strongly and diffusely expressed in all 22 cases of neuroblastomas, but was also focally or multifocally expressed in 9/12 rhabdomyosarcomas and also in the blastema and stroma of 8/11 Wilms tumors. All rhabdomyosarcomas strongly and diffusely express nestin, but this marker was also expressed, multifocally, in 15/22 neuroblastomas and also in the blastema and stroma of all 11 Wilms tumors. NeuN, a neuron-specific nuclear protein, was expressed focally in 1 case of neuroblastoma and diffusely in 2 other cases (3/22). Surprisingly, it was also focally expressed in 2/12 rhabdomyosarcomas. In contrast, all 7 cases of Ewing sarcoma were negative for peripherin, MAP 1B, alpha-internexin, NeuN, and nestin. Thirteen neuroblastomas were also immunostained for neurofilaments, tyrosinase, and anaplastic lymphoma kinase 1 (ALK 1), and were found to be negative for these markers. Our results confirm that peripherin and alpha-internexin are neuroblastoma markers useful for the differential diagnostic work-up of small round cell tumors of childhood. Strong diffuse immunoreactivity for MAP 1B favors a diagnosis of neuroblastoma, whereas strong diffuse immunoreactivity for nestin favors a diagnosis of rhabdomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528283     DOI: 10.1097/PAI.0b013e318165fe78

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  6 in total

1.  Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.

Authors:  D Schult; A Hölsken; M Buchfelder; S-M Schlaffer; S Siegel; I Kreitschmann-Andermahr; R Fahlbusch; R Buslei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

2.  CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor.

Authors:  Vicki S Malone; Sheila M Dobin; Kathleen A Jones; Ludvik R Donner
Journal:  Virchows Arch       Date:  2010-07-09       Impact factor: 4.064

3.  The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Simon Schimmack; Ben Lawrence; Bernhard Svejda; Daniele Alaimo; Hubertus Schmitz-Winnenthal; Lars Fischer; Markus W Büchler; Mark Kidd; Irvin Modlin
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

4.  Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study.

Authors:  J Osman; S Galli; M Hanafy; X Tang; A Ahmed
Journal:  Clin Transl Oncol       Date:  2013-04-04       Impact factor: 3.405

5.  Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma.

Authors:  Ja Hee Suh; Chul-Kee Park; Sung-Hye Park
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

6.  Paraneoplastic neuronal intermediate filament autoimmunity.

Authors:  Eati Basal; Nicholas Zalewski; Thomas J Kryzer; Shannon R Hinson; Yong Guo; Divyanshu Dubey; Eduardo E Benarroch; Claudia F Lucchinetti; Sean J Pittock; Vanda A Lennon; Andrew McKeon
Journal:  Neurology       Date:  2018-10-03       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.